Editors' note: This article discusses one or more penny stocks and/or microcaps. Such stocks are easily manipulated; do your own careful due diligence.
Company: Yungjin Pharmaceutical Company Limited
Bloomberg ticker: 003520 KS
Market cap: US$1,025m
Background: Yungjin Pharmaceutical Company Limited develops, produces, and distributes pharmaceuticals. The product range includes cephalosporin, antibiotics, drugs for the central nervous system, cardiovascular, endocrine system, urinary system, respiratory, anti-inflammatory and analgesics, anti-histamine, anti-fungal, total nutrition, vitamin and supplement, cosmetics, and tonic drinks. Yungjin Pharmaceutical was founded on 29 June 1952 and is headquartered in Seoul, Korea.
World Class Benchmarking of Yungjin Pharmaceutical
(Click on image to enlarge)
- Profitable Growth rank of 1 was up compared to the prior period’s 6th rank
- This is World Class performance compared to 410 medium Health Care companies worldwide
- Profitability rank of 7 was worse than its Growth rank of 1
- Profitability rank of 7 was the same compared to the prior period’s 7th rank
- This is below average performance compared to peers
- Growth rank of 1 was the same compared to the prior period’s 1st rank
- This is World Class performance compared to peers
Comments
Log in or sign up to join the conversation.